United Therapeutics Corp.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $598.2M | $477.4M | $120.8M | $138.5M |
| FY2022 | $802.5M | $663.7M | $138.8M | $106.8M |
| FY2023 | $978.0M | $747.6M | $230.4M | $39.1M |
| FY2024 | $1.33B | $1.08B | $246.5M | $144.0M |
| FY2025 | $1.56B | $1.04B | $520.5M | $147.7M |